Literature DB >> 30789208

Integrated and differentiated methadone and HIV care for people who use drugs: a qualitative study in Kenya with implications for implementation science.

Andy Guise1,2, James Ndimbii3, Emmy Kageha Igonya4, Frederick Owiti4, Steffanie A Strathdee1, Tim Rhodes5.   

Abstract

Integrating methadone and HIV care is a priority in many low- and middle-income settings experiencing a growing challenge of HIV epidemics linked to injecting drug use. There is as yet little understanding of how to integrate methadone and HIV care in these settings and how such services can be implemented; such a gap reflects, in part, limitations in theorizing an implementation science of integrated care. In response, we qualitatively explored the delivery of methadone after its introduction in Kenya to understand integration with HIV care. Semi-structured interviews with people using methadone (n = 30) were supplemented by stakeholder interviews (n = 2) and participant observation in one city. Thematic analysis was used, that also drew on Mol's logic of care as an analytical framework. Respondents described methadone clinic-based care embedded in community support systems. Daily observed clinic care was challenging for methadone and stigmatizing for HIV treatment. In response to these challenges, integration evolved and HIV care differentiated to other sites. The resulting care system was acceptable to respondents and allowed for choice over locations and approaches to HIV care. Using Mol's logic of care as an analytical framework, we explore what led to this differentiation in integrated care. We explore co-production and experimentation around HIV care that compares with more limited experimentation for methadone. This experimentation is bounded by available discourses and materials. The study supports continued integration of services whilst allowing for differentiation of these models to adapt to client preferences. Co-location of integrated services must prioritize clinic organization that prevents HIV status disclosure. Our analysis fosters a material perspective for theory of implementation science and integration of services that focuses attention on local experimentation shaped by context.
© The Author(s) 2019. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; Integration; Kenya; drug policy; treatment

Mesh:

Substances:

Year:  2019        PMID: 30789208      PMCID: PMC6481284          DOI: 10.1093/heapol/czz002

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  3 in total

1.  A systematic review of substance use and substance use disorder research in Kenya.

Authors:  Florence Jaguga; Sarah Kanana Kiburi; Eunice Temet; Julius Barasa; Serah Karanja; Lizz Kinyua; Edith Kamaru Kwobah
Journal:  PLoS One       Date:  2022-06-09       Impact factor: 3.752

2.  Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators.

Authors:  Natasha T Ludwig-Barron; Brandon L Guthrie; Loice Mbogo; David Bukusi; William Sinkele; Esther Gitau; Carey Farquhar; Aliza Monroe-Wise
Journal:  Harm Reduct J       Date:  2021-12-18

3.  The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya.

Authors:  Elizabeth Wambui Ngarachu; Sarah Kanana Kiburi; Frederick R Owiti; Rachel Kangethe
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-02-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.